We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
Read MoreHide Full Article
In the latest close session, Tenet Healthcare (THC - Free Report) was up +2.2% at $191.20. The stock exceeded the S&P 500, which registered a loss of 0.22% for the day. Meanwhile, the Dow lost 0.03%, and the Nasdaq, a tech-heavy index, lost 0.66%.
Shares of the hospital operator witnessed a gain of 14.35% over the previous month, beating the performance of the Medical sector with its gain of 6.47%, and the S&P 500's loss of 1.21%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company is scheduled to release its earnings on July 24, 2026. The company's earnings per share (EPS) are projected to be $4.08, reflecting a 1.49% increase from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $5.39 billion, indicating a 2.27% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $17.61 per share and revenue of $22.02 billion, which would represent changes of +4.95% and +3.32%, respectively, from the prior year.
Any recent changes to analyst estimates for Tenet Healthcare should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Tenet Healthcare is currently sporting a Zacks Rank of #2 (Buy).
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 10.63. Its industry sports an average Forward P/E of 10.63, so one might conclude that Tenet Healthcare is trading at no noticeable deviation comparatively.
Investors should also note that THC has a PEG ratio of 1.54 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. THC's industry had an average PEG ratio of 1.54 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 58, which puts it in the top 24% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
In the latest close session, Tenet Healthcare (THC - Free Report) was up +2.2% at $191.20. The stock exceeded the S&P 500, which registered a loss of 0.22% for the day. Meanwhile, the Dow lost 0.03%, and the Nasdaq, a tech-heavy index, lost 0.66%.
Shares of the hospital operator witnessed a gain of 14.35% over the previous month, beating the performance of the Medical sector with its gain of 6.47%, and the S&P 500's loss of 1.21%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company is scheduled to release its earnings on July 24, 2026. The company's earnings per share (EPS) are projected to be $4.08, reflecting a 1.49% increase from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $5.39 billion, indicating a 2.27% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $17.61 per share and revenue of $22.02 billion, which would represent changes of +4.95% and +3.32%, respectively, from the prior year.
Any recent changes to analyst estimates for Tenet Healthcare should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Tenet Healthcare is currently sporting a Zacks Rank of #2 (Buy).
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 10.63. Its industry sports an average Forward P/E of 10.63, so one might conclude that Tenet Healthcare is trading at no noticeable deviation comparatively.
Investors should also note that THC has a PEG ratio of 1.54 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. THC's industry had an average PEG ratio of 1.54 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 58, which puts it in the top 24% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.